Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)Kalorama InformationFebruary 1, 2007 118 Pages - SKU: KLI1375771 |
Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition 2 Volume II: Implantable / Injectable Systems, the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
|
Related Markets
Drug Delivery Reports
- Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
- Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
- Implantable Medical Devices
- Global Inhaled Antibiotics Market 2011-2015
- Drug Delivery: Surveying the Global Competitive Landscape

